Ocera Therapeutics (OCRX) Tops Q4 EPS by 18c
Tweet
Share
E-mailGet Alerts OCRX Hot Sheet
Join SI Premium – FREE
Ocera Therapeutics (NASDAQ: OCRX) reported Q4 EPS of ($0.28), $0.18 better than the analyst estimate of ($0.46).
For earnings history and earnings-related data on Ocera Therapeutics (OCRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Fox upgraded to overweight as Roku deal, ad strength lift outlook
- Prosensa Holding N.V. (RNA) Reports Q2 Loss of $1.18
- Edible Garden AG (EDBL) Reports Q2 Loss of $18.79
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
